Cargando…
Upper respiratory tract infections
Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091368/ https://www.ncbi.nlm.nih.gov/pubmed/11838568 http://dx.doi.org/10.1007/BF02722930 |
_version_ | 1783510009243500544 |
---|---|
author | Jain, Neemisha Lodha, R. Kabra, S. K. |
author_facet | Jain, Neemisha Lodha, R. Kabra, S. K. |
author_sort | Jain, Neemisha |
collection | PubMed |
description | Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast majority of acute upper respiratory tract infections are caused by viruses. Common cold is caused by viruses in most circumstances and does not require antimicrobial agent unless it is complicated by acute otitis media with effusion, tonsillitis, sinusitis, and lower respiratory tract infection. Sinusitis is commonly associated with common cold. Most instances of rhinosinusitis are viral and therefore, resolve spontaneously without antimicrobial therapy. The most common bacterial agents causing sinusitis areS. pneumoniae, H. influenzae, M. catarrhalis,S. aureus andS. pyogenes. Amoxycillin is antibacterial of choice. The alternative drugs are cefaclor or cephalexin. The latter becomes first line if sinusitis is recurrent or chronic. Acute pharyngitis is commonly caused by viruses and does not need antibiotics. About 15% of the episodes may be due to Group A beta hemolytic streptococcus (GABS). Early initiation of antibiotics in pharyngitis due to GABS can prevent complications such as acute rheumatic fever. The drug of choice is penicillin for 10–14 days. The alternative medications include oral cephalosporins (cefaclor, cephalexin), amoxicillin or macrolides. |
format | Online Article Text |
id | pubmed-7091368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-70913682020-03-24 Upper respiratory tract infections Jain, Neemisha Lodha, R. Kabra, S. K. Indian J Pediatr Special Article Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast majority of acute upper respiratory tract infections are caused by viruses. Common cold is caused by viruses in most circumstances and does not require antimicrobial agent unless it is complicated by acute otitis media with effusion, tonsillitis, sinusitis, and lower respiratory tract infection. Sinusitis is commonly associated with common cold. Most instances of rhinosinusitis are viral and therefore, resolve spontaneously without antimicrobial therapy. The most common bacterial agents causing sinusitis areS. pneumoniae, H. influenzae, M. catarrhalis,S. aureus andS. pyogenes. Amoxycillin is antibacterial of choice. The alternative drugs are cefaclor or cephalexin. The latter becomes first line if sinusitis is recurrent or chronic. Acute pharyngitis is commonly caused by viruses and does not need antibiotics. About 15% of the episodes may be due to Group A beta hemolytic streptococcus (GABS). Early initiation of antibiotics in pharyngitis due to GABS can prevent complications such as acute rheumatic fever. The drug of choice is penicillin for 10–14 days. The alternative medications include oral cephalosporins (cefaclor, cephalexin), amoxicillin or macrolides. Springer India 2001 /pmc/articles/PMC7091368/ /pubmed/11838568 http://dx.doi.org/10.1007/BF02722930 Text en © Dr. K C Chaudhuri Foundation 2001 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Special Article Jain, Neemisha Lodha, R. Kabra, S. K. Upper respiratory tract infections |
title | Upper respiratory tract infections |
title_full | Upper respiratory tract infections |
title_fullStr | Upper respiratory tract infections |
title_full_unstemmed | Upper respiratory tract infections |
title_short | Upper respiratory tract infections |
title_sort | upper respiratory tract infections |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091368/ https://www.ncbi.nlm.nih.gov/pubmed/11838568 http://dx.doi.org/10.1007/BF02722930 |
work_keys_str_mv | AT jainneemisha upperrespiratorytractinfections AT lodhar upperrespiratorytractinfections AT kabrask upperrespiratorytractinfections |